Article
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
2020-01-30
Abstract excerpt
Failed T cell-based immunotherapies in the presence of genomic alterations in antigen presentations pathways may be overcome by NK cell-based immunotherapy. This approach may still be limited by the presence of immunosuppressive myeloid populations. Here we demonstrate that NK cells (haNKs) engineered to express a PD-L1 chimeric antigen receptor (CAR) haNKs killed a panel of human and murine head and neck cancer c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a284975e-ae1d-59d3-a381-646a629d60ed
- DOI
- 10.1101/2020.01.30.926535
